- Messages
- 8,453
- Type of diabetes
- Type 2
- Treatment type
- Tablets (oral)
In a nutshell. What a salvo that article has in it. Very investigative journalism and the best takedown I have seen in ages, The proof is in the pudding.![]()
Revealed: experts who praised new âskinny jabâ received payments from drug maker
Novo Nordisk gave millions to obesity charities and healthcare professionals, including expert who advised Nicewww.theguardian.com
Quelle surprise!
Beware of lookalikes that are cheaper because they have been diluted with other additives to get round the FDA regulations
Obesity specialists warn against 'bootleg' weight-loss drug
Semaglutide, a weight-loss drug developed by Novo Nordisk, is currently in short supply due to high demand, leading some people to seek out

Note that the FDA ha a warning about possible thyroid cancer for this drug and we have seen at least two forum members reporting such dignosis after starting this drug.
There is also reports of DKA in insulin users on this drug.
The Mayo Clinic which is a diabetes Centre of Excellence, reports a large list of drugs that are not compatible with Ozempic
Now I suspect that this will to a certain extent be controlled for us T2D diabetics, but the general public using Wegovy at a much higher dose and a 2 year treatment phase are currently able to get it online and the only limitation on the application is BMI (weight and height) and that is self declaraton, and not from medical records. ?The public are not being given this info so far. We have a Wunderkindt on the block.